ATAD3A and metabolic dysfunction-associated steatohepatitis: To gain insight into the function of ATAD3A in the progression of NAFLD, we characterized ATAD3A expression in liver samples from rats with NASH along with matching controls and liver specimens from patients with SS, NASH, cirrhosis, or normal tissue.